Requirements for a Lead Compound to Become a Clinical Candidate
Author Information
Author(s): Franz F Hefti
Primary Institution: Avid Radiopharmaceuticals, Inc.
Conclusion
The path from lead to clinical drug candidate is complex and often unpredictable, requiring careful consideration of safety and efficacy.
Supporting Evidence
- Drug candidates must bind selectively to target receptors and elicit desired responses.
- The drug discovery process is complex and often unpredictable, with high attrition rates.
- Safety and toxicity data are critical for regulatory approval of new drug candidates.
Takeaway
Finding a new medicine is like a treasure hunt where scientists look for special compounds that can help people, but it’s really hard and takes a long time.
Methodology
The review discusses the criteria and processes involved in selecting drug candidates for clinical testing, including safety evaluations and pharmacokinetic studies.
Potential Biases
Potential bias due to the author's affiliation with a pharmaceutical company.
Limitations
The review does not provide specific data or case studies to illustrate the discussed concepts.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website